Crohn's Disease
Crohn's Disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Crohn's Disease: Tulisokibart Treatment Study
We are testing a new medication, tulisokibart, for people with moderately to severely active Crohn's disease. The study aims to see if it helps reduce symptoms and achieve remission compared to a placebo.
>2 yearsConfirmation phase (III)Post-Trial Drug AccessCost ReimbursementInvestigational MedicinesInjectionGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 16 and 18 years old?
- Do you have Crohn’s Disease (CD) diagnosed at least 3 months ago?
- Do you have moderately to severely active Crohn’s Disease?
- Have you had an inadequate response or intolerance to treatments like steroids or biologics?
- Do you have any history of cancer that is not fully treated and disease-free for at least 5 years?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Tulisokibart
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medizinische Universitaet Innsbruck
Medizinishe Universität Innsbruck Universitätsklinik für Innere Medizin I
Innsbruck, Austria
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Uniklinikum Salzburg Universitätsklinik für Innere Medizin I Landeskrankenhaus
Salzburg, Austria
Medical University Of Vienna
Medinzinische Universität Wien Abteilung für Gastroenterologie und Hepatologie, 7I
Vienna, Austria
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.